373110 — Xcell Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Xcell Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,632	5,556	1,359	8,802	6,606
Net Total Accounts Receivable
Net Total Receivables	273	648	623	920	726
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15,425	7,216	4,421	10,512	9,637
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,515	7,372	5,355	4,472	4,193
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	23,702	15,509	10,468	16,890	15,721
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5,258	5,187	5,443	4,906	5,332
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	7,477	7,026	8,085	7,769	8,583
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	16,225	8,483	2,384	9,121	7,138
Total Liabilities & Shareholders' Equity	23,702	15,509	10,468	16,890	15,721
Total Common Shares Outstanding